Form 4: Elanco Exec Buys Shares, Acquires Stock Units

Sentiment:

Insider Transaction Report


Rajeev A. Modi, Executive Vice President at Elanco Animal Health, acquired company shares and deferred stock units on May 15, 2026.

Summary

  • Rajeev A. Modi, Executive Vice President of U.S. Pet Health and Global Digital Transformation at Elanco Animal Health Inc., reported transactions on May 15, 2026.
  • Modi acquired 4,911 shares of common stock at a price of $20.35 per share.
  • Following this acquisition, Modi beneficially owns 160,812 shares of common stock.
  • Additionally, Modi acquired 74.3671 deferred stock units, which represent the right to receive one share of common stock or its cash equivalent.
  • These deferred stock units are valued at $19.86 each and settle upon termination of employment or in a specified future year.
  • Modi's total holdings of these deferred stock units amount to 9,339.9884.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it reflects an executive's investment in the company, but it does not contain broader financial performance data.

Positives

  • Executive leadership is investing in the company's stock, as evidenced by the purchase of 4,911 shares.
  • The acquisition of deferred stock units suggests a long-term incentive and commitment from a key executive.

Future Outlook

The deferred stock units are set to settle in cash or shares of Company common stock following termination of employment or during a specified future year, indicating a long-term vesting and payout structure.

Industry Context

StockSavvy.ai notes that insider transactions, such as this stock purchase by an executive, can sometimes be interpreted as a signal of confidence in the company's future prospects within the animal health industry.

Stakeholder Impact

  • Shareholders may view the executive's stock purchase as a positive signal of confidence in the company's value.
  • Employees may be influenced by executive actions regarding stock ownership, particularly if they participate in similar equity incentive plans.

Key Dates

DateDescription
05/15/2026Date of earliest transaction and transaction date for stock acquisition and deferred stock unit acquisition.
05/19/2026Date of signature for the filing.

Keywords

Elanco Animal Health, Form 4, Insider Trading, Stock Acquisition, Deferred Stock Units, Rajeev A. Modi, Securities Exchange Act, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.